Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,526 public trials 2,840 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants Above 19 Years of Age With Acute Myeloid Leukemia (AML)

NCT04826523

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Pusan National University Hospital /ID# 239010 Busan, Busan Gwang Yeogsi, South Korea
  • Kosin University Gospel Hospital /ID# 257399 Busan, Busan Gwang Yeogsi, South Korea
  • Kyungpook National University Hospital /ID# 257398 Daegu, Daegu Gwang Yeogsi, South Korea
  • Gachon University Gil Medical Center /ID# 239008 Incheon, Gyeonggido, South Korea
View Trial Details
Completed

Lenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin Lymphoma

NCT02568553

Conditions
Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +53 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
View all 24 locations
View Trial Details
Completed

Impact of Congenital Heart Disease on the Prognosis of Childhood Hematological Neoplasms: A Multicenter Cohort Study

NCT07249138

Conditions
Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +10 more
Locations
  • Beijing Children's Hospital Beijing, China
  • The Third Xiangya Hospital of Central South University Changsha, China
  • Guangzhou Women and Children's Medical Center Guangzhou, China
  • Inner Mongolia Maternal and Child Health Care Hospital Hohhot, China
View all 18 locations
View Trial Details
Completed

A Multicenter Open Label Phase II Study of Pomalidomide and Cyclophosphamide and Dexamethasone in Relapse/Refractory Multiple Myeloma Patients Who Were First Treated Within the IFM/DFCI 2009 Trial (PCD)

NCT02244125

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • CHRU Hopital Sud Amiens, France
  • Centre Hospitalier de la côte Basque Bayonne, France
  • Hôpital Avicenne Bobigny, France
  • ICH - Hôpital A. Morvan Brest, France
View all 30 locations
View Trial Details

Related conditions